Alterations in the translocation of the intestinal microbiota appear to be associated with L-FABP and I-FABP, which are recognized early serological markers of intestinal epithelial damage in MASLD [24]. Here, FABP1 is linked to metabolic dysfunction-associated steatotic liver disease.